Hallie Hoskins

Associate Partner & Gene Therapy Biosafety Officer

Hallie Hoskins started her career isolating cell lines for research, then segued into the field of biological safety shortly thereafer. She has biosafety experience in academia, at University of Maryland College Park and University of Oregon, as well as contract production of therapeutics in preclinical trials. An active member of ABSA, she maintains RBP and CBSP credentials. She has a BS from James Madison University, an MS in Biotechnology from Johns Hopkins University, and an MBA from University of Maryland University College. Originally hailing from Virginia, she currently resides (and loves) the Pacific Northwest. In her spare time she enjoys knitting, hiking with her pit bull, sampling craft beers, and dreaming of converting a school bus to travel full-time.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.